Eli Lilly says antibodies reduce COVID-19 deaths and hospitalizations by 87 percent
Eli Lilly announced on Wednesday that its antibody drug to fight coronavirus reduced the risk of hospitalization and death from the disease by 87 percent. In a new study of 769 high-risk COVID-19 p…
